Exploring emergency contraception prescribing by pharmacists in California


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 04 2019
revised: 27 08 2019
accepted: 29 08 2019
pubmed: 8 9 2019
medline: 22 9 2020
entrez: 8 9 2019
Statut: ppublish

Résumé

To understand knowledge, current practices, barriers and facilitators for pharmacists prescribing emergency contraception (EC). We conducted a cross-sectional survey among California community pharmacists. We distributed the online survey, consisting of 34 close-ended questions, to members of the California Pharmacists Association via its email listserve. We collected a survey response rate of 7%. Although 95% of respondents were aware of the statewide protocol allowing pharmacists to prescribe EC, only 36% of respondents reported prescribing EC in the previous year. Prescribing practices within the past year differed by type of pharmacy. We found no correlation between EC knowledge and prescribing practices. The most frequently reported facilitators of EC prescribing by pharmacists were the statewide protocol, a continuing education training program, and patient need or demand for EC. The most reported barriers to prescribing EC were lack of payment for pharmacist patient care services by insurers, increased responsibility or liability concerns, and time constraints. When asked about their intention to prescribe in the upcoming year, responses differed based on whether or not their pharmacies currently stocked EC. This exploratory study identifies key facilitators, such as the statewide protocol, and key barriers, such as lack of payment by insurance companies for pharmacist services. The findings of this study could guide future multi-component implementation strategies such as academic detailing that specifically address concerns about increased responsibility, liability and time constraints. In addition, payment for pharmacist services could be addressed at a policy level since this was a barrier to pharmacist EC prescribing.

Identifiants

pubmed: 31493380
pii: S0010-7824(19)30409-3
doi: 10.1016/j.contraception.2019.08.012
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-467

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sheila K Mody (SK)

Division of Family Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, United States. Electronic address: smody@ucsd.edu.

Sally Rafie (S)

Department of Pharmacy, UC San Diego Health, San Diego, CA, United States.

Marisa Hildebrand (M)

Division of Family Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, United States.

Lisa P Oakley (LP)

College of Public Health and Human Sciences, Oregon State University, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH